Micro-reaction technology offers a safe way to deliver diazomethane on demand both on the R&D and the industrially relevant scale, including in situ conversion to the desired product to avoid handling and storage of explosive diazomethane solutions, thus making this potent compound accessible for the pharmaceutical and fine chemical sector.
No takes yet. Share an insight, caveat, or question.
Struempel et al. (2007) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: